Immunomodulation: NK cells activated by interferon-conjugated monoclonal antibody against human osteosarcoma
- 1 June 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (6) , 791-798
- https://doi.org/10.1016/0277-5379(84)90218-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Characteristics of a cell surface antigen defined by an anti-human osteogenic sarcoma monoclonal antibodyEuropean Journal of Cancer and Clinical Oncology, 1983
- RADIOIMMUNODETECTION OF HUMAN COLORECTAL CANCERS BY AN ANTI-TUMOUR MONOCLONAL ANTIBODYThe Lancet, 1982
- Expression of a monoclonal antibody-defined liver-associated antigen in normal rat hepatocytes and hepatocellular carcinoma cellsInternational Journal of Cancer, 1982
- Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantationNature, 1982
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- The clinical value of interferons as antitumor agentsEuropean Journal of Cancer and Clinical Oncology, 1981
- Natural killer cells infiltrate transplanted chemically induced sarcomasCellular Immunology, 1981
- A MICROASSAY FOR THE DETECTION OF TUMOUR-SPECIFIC COMPLEMENT-DEPENDENT SERUM CYTOTOXICITY AGAINST A CHEMICALLY INDUCED RAT HEPATOMATransplantation, 1978
- Decreased “natural killer” effect in tumor‐bearing mice and its relation to the immunity against oncorna virus‐determined cell surface antigensEuropean Journal of Immunology, 1976
- TUMOR INFILTRATING LYMPHOCYTES*Annals of the New York Academy of Sciences, 1976